EUVIMEDFaigh amach EUVIMED
Crossref

Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients

Mary Grace Fitzmaurice iD, Benjamin Hohlfelder iD, Pavithra Srinivas iD, Michael Rudoni iD, Kyle D Brizendine iD, Marie Budev iD

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15079 ↗

At a glance

Journal article in Clinical Transplantation, 2023. Written by Mary Grace Fitzmaurice and 5 co-authors. Institution: Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA. Major MEDLINE topics: Clostridioides difficile, Clostridium Infections, Lung Transplantation, Primary Prevention. 10 references.

AchoimreSubjectsSonraí leabharliostaCiteRelated studies

Abstract (original language)

Lung transplant recipients are at an increased risk for Clostridioides difficile infection (CDI), and those who develop CDI post-transplant can have worsened outcomes including graft failure and death. We sought to describe the efficacy and safety of primary CDI prophylaxis with oral vancomycin among 86 adult lung transplant recipients. Overall, we observed a 9.3% (8/86) incidence of CDI among patients receiving prophylaxis, with the majority of infections occurring a median of 25 days after completion of prophylaxis. Furthermore, we observed a 4.7% incidence of VRE infection/colonization. Opportunities exist to optimize the duration of CDI prophylaxis to balance the benefits and risks in lung transplant recipients.

Subjects

MeSH terms (MEDLINE)

Clostridioides difficileClostridium InfectionsLung TransplantationPrimary PreventionVancomycinAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdministration, OralIncidence

Author keywords

antibiotic prophylaxisbacterial: Clostridium difficileinfection and infectious agentslung (allograft) function/dysfunction

Substances

VancomycinAnti-Bacterial Agents

Authors and institutions

  • Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pharmacy and Transplant Institute, Henry Ford Health, Detroit, MI, USA.
  • Department of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID profiles: Mary Grace Fitzmaurice, Benjamin Hohlfelder, Pavithra Srinivas, Michael Rudoni, Kyle D Brizendine, Marie Budev

Cite

APA

Fitzmaurice, M. G., Hohlfelder, B., Srinivas, P., Rudoni, M., Brizendine, K. D., & Budev, M. (2023). Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15079

Vancouver

Fitzmaurice MG, Hohlfelder B, Srinivas P, Rudoni M, Brizendine KD, Budev M. Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients. Clinical Transplantation. 2023. doi:10.1111/ctr.15079

BibTeX
@article{Fitzmaurice2023,
  author = {Fitzmaurice, Mary Grace and Hohlfelder, Benjamin and Srinivas, Pavithra and Rudoni, Michael and Brizendine, Kyle D and Budev, Marie},
  title = {Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15079}
}
Start for free →